Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for identifying lymphocyte subpopulations infected by EB (epstein-barr) virus and proportion of injected cells in lymphocyte subpopulations and application of method

A technology for lymphocytes and infected cells, which is applied in the field of medical testing, can solve the problems of inability to effectively distinguish the type of lymphocytes infected by EBV and the proportion of infected cells, and achieve improved prognosis, strong universality, and accurate detection results Effect

Inactive Publication Date: 2019-01-04
北京倍科为生物技术有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The first object of the present invention is to provide a method for distinguishing EB virus-infected lymphocyte subgroups and the proportion of infected cells in the subgroup cells, so as to alleviate the inability of the current domestic general EBV-DNA detection existing in the prior art. Technical issues of effectively distinguishing EBV-infected lymphocyte types and the proportion of infected cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for identifying lymphocyte subpopulations infected by EB (epstein-barr) virus and proportion of injected cells in lymphocyte subpopulations and application of method
  • Method for identifying lymphocyte subpopulations infected by EB (epstein-barr) virus and proportion of injected cells in lymphocyte subpopulations and application of method
  • Method for identifying lymphocyte subpopulations infected by EB (epstein-barr) virus and proportion of injected cells in lymphocyte subpopulations and application of method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] The pretreatment of embodiment 1 lymphocyte

[0060] 1. Extraction of human peripheral blood mononuclear cells (HPBMC)

[0061] 1. Put 6mL of fasting venous blood into a sterile test tube anticoagulated with EDTA, dilute it by 1 time with PBS, and then separate PBMC with lymphocyte separation medium (2000 rpm for 20 minutes);

[0062] 2. Aspirate the middle buffy coat layer, add 10mL PBS, 1400rpm, 10min to wash and precipitate PBMC;

[0063] 3. Discard the supernatant, add 2mL erythrocyte lysate (Solebo erythrocyte lysate product number: Cat#R1010) to lyse, mix well, and incubate at room temperature for 5 minutes;

[0064] 4. After fully mixing, absorb 20 μL of cells and dilute them with 2% glacial acetic acid at 1:3, take the first reading with a cell counter, and record the readings;

[0065] 5. Fill up with PBS, centrifuge at 1400rpm for 10min, discard the supernatant, and obtain human peripheral blood mononuclear cells.

[0066] 2. Surface staining of human perip...

Embodiment 2

[0082] Embodiment 2 probe hybridization and on-machine detection

[0083] 1. Target-specific probe hybridization

[0084] 1. Prepare probe diluent (mixed probes with nucleotide sequences as shown in SEQ ID NO.1, SEQ ID NO.2 and SEQ ID NO.3). Preheat the Target Probe Diluent to 40°C in advance, and dilute the 20× probe to 1×. Each sample requires 100 μL of Probe Diluent. Add 5 μL of EBER probe to 95 μL of Target Probe Diluent, and mix well by pipetting up and down;

[0085] 2. Add 100 μL of the diluted probe directly into the cell suspension, and be careful not to hit the probe on the tube wall. Vortex evenly, incubate at 40°C for 2 hours, mix the sample upside down after 1 hour of hybridization, and continue to complete the hybridization for the last 1 hour;

[0086] 3. Add 1 mL of Wash Buffer to each sample, invert to mix, centrifuge at 800×g for 5 min, discard the supernatant until 100 μL remains, and use the residual liquid to resuspend the cells;

[0087] 4. Prepare W...

Embodiment 3

[0102] In this example, the method for identifying EBV-infected lymphocyte subgroups and the proportion of infected cells in the subgroup provided by the present invention was used to detect the EBV infection of peripheral blood lymphocytes of an EBV-positive patient. Wherein, the method provided in Example 1 was used for pretreatment of lymphocytes, and the method provided in Example 2 was used for probe hybridization and on-machine detection. The objects tested on the machine are CD3+T, CD4+T, CD8+T, CD19+B, CD56+NK EBV infection.

[0103] The test results are shown in the figure.

[0104] in, Figure 3A It is the detection result chart of the blank control tube of CD19+ B cells without adding EBER probe in this patient, Figure 3B Diagram of the detection results of CD19+ B cells added with EBER probes for this patient; from Figure 3A and Figure 3B As can be seen in , the results show that 11.85% of the CD19+ B cells in this patient were infected with EBV. Figure 4A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for identifying lymphocyte subpopulations infected by an EB (epstein-barr) virus and a proportion of injected cells in the lymphocyte subpopulations and application ofthe method, and relates to the technical field of medical test. According to the method, a probe is mixed with a mononuclear cell extracted from preprocessed peripheral blood, and after hybridization,a flow cytometry measurement method is adopted to acquire and analyze to identify the lymphocyte subpopulations infected by the EB virus and the proportion of the injected cells in the lymphocyte subpopulations. The method has the advantages that the type of cells infected by the EBV (epstein-barr virus) can be found out accurately, the proportion of the infected cells in the lymphocyte subpopulations can be found out, according to the type of the cells infected by the EBV and the proportion of the infected cells, a targeted therapeutic schedule can be beneficially made to effectively and accurately treat diseases caused by EBV injection, and accordingly the method plays important roles in implement of accurate therapy and prognosis improvement of a patient.

Description

technical field [0001] The invention relates to the technical field of medical detection, in particular to a method for distinguishing Epstein-Barr virus-infected lymphocyte subgroups and the proportion of infected cells in the subgroup cells and its application. Background technique [0002] Epstein-Barr virus (EBV) belongs to type 4 herpes virus, and is associated with infectious mononucleosis (IM) and EBV-related lymphoproliferative disorders (Epstein-Barr virusrelated lymphoproliferative disorders, EBV-LPD) , Burkitt lymphoma and nasopharyngeal carcinoma and other diseases are closely related, but also chronic active EBV infection (chronic active EBV infection syndrome, CAEBV), EBV-related hemophagocytic lymphohistiocytosis (Epstein-Barr virus related hemophagocytic lymphohistiocytosis) , EBV-HLH) and EBV-related T lymphocyte lymphoma (Epstein-Barr virus genome positive T cell lymphoma), NK cell leukemia / lymphoma, Hodgkin lymphoma and other diseases. [0003] Hemophagoc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/682
CPCC12Q1/682C12Q2565/518
Inventor 卓频
Owner 北京倍科为生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com